No Data
No Data
Are Bide Pharmatech Co., Ltd.'s (SHSE:688073) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Bide Pharmatech (SHSE:688073) has had a rough three months with its share price down 26%. However, stock prices are usually driven by a company's financials over the long term, which in this case lo
Express News | A-share review: the three major indices collectively adjusted the turnover of the two markets exceeded trillion dollars for five consecutive trading days
Bide Pharmaceutical (688073.SH): Dai Lan increased its holdings by 35,000 shares
Gelonghui, March 20, 丨 Bide Pharmaceutical (688073.SH) announced that from January 24, 2024 to March 19, 2024, Ms. Dai Lan has accumulated 35,000 shares of the company's shares through centralized bidding through the Shanghai Stock Exchange trading system, accounting for 0.0385% of the company's total share capital. The total increase amount is RMB 1.407 million (excluding transaction fees), which has exceeded 50% of the minimum amount of RMB 2.5 million of the current increase plan. Entities that increase their holdings will continue to increase their public holdings during the implementation period of the plans to increase their holdings in accordance with the relevant plans to increase their holdings
Bide Pharmaceutical (688073.SH): The company has not used AI technology
Gelonghui, March 20 | Bide Pharmaceutical (688073.SH) said on the investor interactive platform that at present, the company has not used AI technology. At the same time, the company has been keeping an eye on the progress of AI technology in the field of new drug development.
5.162,200 restricted shares of Bide Pharmaceutical (688073.SH) will be listed and circulated on March 25
Bide Pharmaceutical (688073.SH) announced that the restricted shares currently in circulation are part of the company's initial public offering...
Bide Pharmaceutical (688073.SH): It has spent 704.314 million yuan to buy back a total of 1.7783% of the company's shares
Gelonghui, March 4, 丨 Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company had repurchased a total of 1.616,200 shares of the company's shares through the Shanghai Stock Exchange trading system, accounting for 1.7783% of the company's total share capital of 90,882,948 shares. The highest price of the repurchase transaction was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total transaction amount was 704.314 million yuan (excluding transaction fees).
No Data